项目委员会
-
Daniel Millar, MBA Senior Director, Strategic Business Transformation
Johnson & Johnson, United States -
Abby Bronson, MBA Vice President, Patient Advocacy and External Innovation
Edgewise Therapeutics, United States -
Amy Burd, PHD Chief Scientific Officer
Eilean Therapeutics, United States -
Michelle A Detry, PHD Director, Adaptive Trial Execution & Senior Statistical Scientist
Berry Consultants, LLC, United States -
Sudheer Doss, PHD Chief Data Officer and Head of Business Development
Pancreatic Cancer Action Network, United States -
AnnCatherine M. Downing, PHARMD Chief Operating Officer - Lilly Research Laboratories
Eli Lilly and Company, United States -
Kimberly Ann Fisher, MA Project Manager for Master Protocol Project
Clinical Trials Transformation Initiative (CTTI), United States -
Scott Berry, PHD President and Senior Statistical Scientist
Berry Consultants LLC, United States -
Lisa LaVange, PHD Professor Emerita
University of North Carolina at Chapel Hill, United States
